X

Trial Profile

Prognostic, Anti-arrhythmic, and Ventricular Remodeling Effects of High Dose Fish Oil in Patients With a Recent Myocardial Infarction

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 29 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Omega-3-acid ethyl esters (Primary)
Indications Myocardial infarction
Focus Therapeutic Use
Acronyms Omega-REMODEL

Most Recent Events

29 Feb 2024 Results assessing the impact of O3-FA on adverse cardiac events in long-term follow up post AMI published in the International Journal of Cardiology
09 Dec 2019 Results of post hoc analysis evaluatingthe hypothesis that insulin resistance modifies the therapeutic response of O-3FA during the convalescent phase of acute MI published in the American Journal of Cardiology
08 Oct 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com